✨
AI Summary
- Dr. Doug re-evaluates osteoporosis drugs, shifting his perspective on their long-term risks.
- Explains Prolia's mechanism, research findings, and the significant rebound effect upon discontinuation.
- Shares his updated 2026 osteoporosis medication ranking, emphasizing the need for a clear stopping plan.